Detalhe da pesquisa
1.
Global absence and targeting of protective immune states in severe COVID-19.
Nature
; 591(7848): 124-130, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33494096
2.
Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion.
Immunity
; 44(1): 179-193, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26789923
3.
Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19.
Nature
; 596(7872): E8, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341540
4.
Transcriptional space-time mapping identifies concerted immune and stromal cell patterns and gene programs in wound healing and cancer.
Cell Stem Cell
; 30(6): 885-903.e10, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37267918
5.
Critical role of CD206+ macrophages in organizing anti-tumor immunity.
bioRxiv
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961697
6.
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling.
iScience
; 26(10): 107813, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37810211
7.
CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function.
Nat Commun
; 11(1): 6171, 2020 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268774
8.
Global Absence and Targeting of Protective Immune States in Severe COVID-19.
Res Sq
; 2020 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140041
9.
Global Absence and Targeting of Protective Immune States in Severe COVID-19.
bioRxiv
; 2020 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140050
10.
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.
Cancer Cell
; 35(3): 473-488.e6, 2019 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30889381